Wall Street Is Betting That SNDL Stock Can More Than Double in the Next Year. Should You Buy Shares Here?

SNDL (SNDL) shares gained nearly 12% on Wednesday. Dec. 16 following reports that President Donald Trump could reclassify cannabis as a “Schedule III” drug by the end of this week. The U.S. government is considering a policy shift that would offer some seniors access to cannabis products under Medicare coverage as well, the reports added. More News from Barchart SNDL stock has been a volatile investment this year. Despite a sharp rally on Tuesday, it’s down more than 25% versus its year-to-date high in ...